Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 3 of 512345

GSK wins new reprieve as Hikma’s generic Advair delayed again

The FDA insisted Hikma conduct a further clinical study evaluating its generic version of GlaxoSmithKline’d blockbuster lung drug.

Read More »

AstraZeneca lung cancer trial results pushed back

AstraZeneca expects a key lung cancer study of two immunotherapy drugs to produce overall survival results in the second half of 2018, rather than the first half.

Read More »

Regeneron/Sanofi heart drug succeeds in major trial

A potent, expensive cholesterol drug sold by Regeneron Pharmaceuticals and Sanofi significantly reduced major adverse heart events in a huge study.

Read More »

MyoKardia Reports Positive Results in Heart Study

Shares of MyoKardia climbed after the company revealed positive results from a mid-stage clinical trial for obstructive hypertrophic cardiomyopathy.

Read More »

AcelRx Plans to Resubmit NDA for Dsuvia

AcelRx Pharmaceuticals intends to resubmit a New Drug Application for Dsuvia (sufenetanil sublingual tablet) for pain in Q2 2018 after receiving a Complete Response Letter in October 2017.

Read More »

Xeris Raises $55 Million for Glucagon Rescue Pen

The funds raised will be used to prepare a New Drug Application and funnel into commercial preparation for Xeris Pharmaceuticals Inc.’s lead product candidate, a ready-to-use glucagon rescue pen to treat severe low blood sugar in diabetes patients and individuals with related disorders.

Read More »

Rhode Island doctor in Insys opioid kickback probe faces sentencing

A Rhode Island doctor is to be sentenced after admitting that he took kickbacks from Insys Therapeutics Inc. in exchange for prescribing a fentanyl-based cancer pain drug produced by the company.

Read More »

U.S. says Idaho cannot sell health plans not compliant with Obamacare

A U.S. government agency said Idaho could not allow health insurers to sell plans that do not comply with Obamacare, a sign that the Trump administration will enforce the law even as it takes regulatory actions to weaken the ACA.

Read More »

FDA panel backs Xeljanz as bowel disease treatment

Pfizer Inc.’s Xeljanz should be approved to treat patients with moderate to severe ulcerative colitis, a chronic bowel disease, a U.S. Food and Drug Administration advisory committee concluded.

Read More »

McCann Health Promotes Briana Ferrigno to President McCann Global Health

NEW YORK (March 8, 2018) — McCann Health, winner of an unprecedented total of three Network of the Year titles from the industry’s top three creative award shows in 2017, today announced the promotion of Briana Ferrigno, to President, McCann Global Health. McCann Global Health (MGH) is a specialist agency of McCann Health dedicated to […]

Read More »

Abiomed settles case over lavish doctor meals

Abiomed Inc. agreed to pay $3.1 million to resolve a U.S. probe into allegations that the company sought to get doctors to use a line of heart pumps it produced by buying them lavish meals.

Read More »

FCB Health Launches New Offering

BX: Brand Experience Design Group is a full-service branding agency dedicated to the development of verbal, visual and sensory brand identities across healthcare and wellness.

Read More »

Pfizer Terminates PDC Agreement with CytomX Therapeutics

Pfizer Inc. notified CytomX Therapeutics Inc. of its intent to terminate a five-year-old oncology collaboration with the Bay Area-based company.

Read More »

Prevail Therapeutics Grabs $75 Million to Advance Parkinson’s Disease Programs

Seven months after Prevail Therapeutics launched, the New York-based company secured $75 million in Series A financing to support the development of gene therapies for Parkinson’s disease and other neurodegenerative diseases.

Read More »

Cigna to buy Express Scripts

U.S. health insurer Cigna Corp. will buy pharmacy benefits manager Express Scripts Holding Co., a tie-up that reflects pressure on healthcare companies to grow bigger to cut costs.

Read More »

DiD Certified by the WBENC as a Women-Owned Business Enterprise

DiD, an advertising agency specializing in healthcare marketing, announced national certification as a Women-Owned Business Enterprise by the Women’s Business Enterprise National Council.

Read More »

Sanofi, Evotec team up for research plarform

Sanofi and Evotec started exclusive talks over accelerating research into the treatment of infectious diseases and will form a new open innovation platform in this area, led by Evotec.

Read More »

Roche names Pao head of drugs research and early development

Roche named U.S. cancer expert William Pao head of the Swiss drugmaker’s Pharma Research and Early Development business after John Reed decided to leave for what it called personal reasons.

Read More »

Drinking problems tied to higher risk of early dementia

Heavy drinkers may be more likely than other adults to develop dementia, especially in middle age, a French study suggests.

Read More »

Eisai, Merck Enter Strategic Oncology Collaboration

Eisai and Merck agreed upon a strategic collaboration for the worldwide co-development and co-commercialization of Lenvima (lenvatinib mesylate), an orally available tyrosine kinase inhibitor.

Read More »

Page 3 of 512345

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

February 2018 Focus: Top 10 Pipelines, Focused Value in Pharma, Agenda 2018 and MAHF!


Ad Right Bottom

Main Navigation